肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

RRM1 O-GlcNAc糖基化抑制通过TK1介导的复制应激抑制胰腺癌

RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress 

原文发布日期:2025-03-28

英文摘要:

摘要翻译:

原文链接:

文章:

RRM1 O-GlcNAc糖基化抑制通过TK1介导的复制应激抑制胰腺癌

RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress 

原文发布日期:2025-03-28

英文摘要:

O-GlcNAcylation of ribonucleotide reductase large subunit M1 (RRM1) at position 734 influences high glucose-induced genomic instability and cell transformation in normal pancreatic cells. By disrupting the ribonucleotide reductase complex, it reduces dNTPs. Although the impact of RRM1 O-GlcNAcylation on pancreatic cancer progression remains unexplored, our CRISPR knock-in technology created the RRM1-T734A mutation to minimize RRM1 O-GlcNAcylation. In pancreatic cancer PANC-1 cells with this mutation, we observed heightened replication stress-induced DNA damage, S-phase delays, and diminished in vitro tumor cell growth. Mechanistically, RRM1-T734A enhanced its interaction with RRM2 while impairing binding to RRM2B, leading to decreased NTPs and disrupted dNTP equilibrium. Notably, it doubled dTTP levels via TK1 stabilization mediated by thymidine, resulting in S-phase delay. TK1 silencing restored RRM1-T734A-induced effects on S-phase retardation and decreased colony formation. Our findings highlight the pivotal role of O-GlcNAcylation of RRM1 at T734 in maintaining genomic stability and promoting pancreatic cancer malignancy. Furthermore, reducing RRM1 O-GlcNAcylation increased pancreatic cancer cell sensitivity to gemcitabine, proposing a potential therapeutic strategy. 

摘要翻译:

核糖核苷酸还原酶大亚基M1(RRM1)第734位的O-GlcNAc糖基化修饰影响高糖诱导的正常胰腺细胞基因组不稳定性和细胞转化。该修饰通过破坏核糖核苷酸还原酶复合体降低dNTPs水平。尽管RRM1 O-GlcNAc修饰对胰腺癌进展的影响尚未明确,我们利用CRISPR基因敲入技术构建了RRM1-T734A突变体以最小化其O-GlcNAc修饰。在携带该突变的胰腺癌PANC-1细胞中,我们观察到复制应激诱导的DNA损伤增强、S期阻滞以及体外肿瘤细胞生长减弱。机制上,RRM1-T734A突变增强了与RRM2的相互作用,但削弱了与RRM2B的结合,导致NTPs减少和dNTP平衡破坏。值得注意的是,该突变通过胸苷介导的TK1稳定性使dTTP水平翻倍,进而引发S期延迟。沉默TK1可逆转RRM1-T734A突变诱导的S期阻滞效应并恢复集落形成能力。我们的研究揭示了RRM1 T734位点O-GlcNAc修饰在维持基因组稳定性和促进胰腺癌恶性进展中的关键作用。此外,降低RRM1 O-GlcNAc修饰可增强胰腺癌细胞对吉西他滨的敏感性,这为治疗策略提供了新方向。

原文链接:

RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……